Programmed cell death 1 ligand 1 (PD-L1) and Vessel Encapsulating Tumor Clusters (VETC) are critical biomarkers influencing immune evasion and metastasis, making them pivotal for guiding treatment decisions. This evidence concerns the gene CD274 and neoplasm.